mp.weixin.qq.com·· 4 hours agoPickScore68
Bio-Thera Secukinumab Biosimilar BAT2306 Wins Approval as World's First
In brief
Bio-Thera's BAT2306, a biosimilar of secukinumab, has been approved by China's NMPA, making it the first approved secukinumab biosimilar worldwide. The originator secukinumab, developed by Novartis, is a fully human IgG1 monoclonal antibody that selectively binds IL-17A, blocking its interaction with the receptor and exerting an anti-inflammatory effect.
Why it matters
The brief gives both the approval of BAT2306 and the IL-17A-targeting mechanism as background on its relation to the originator.
Source: mp.weixin.qq.com · mp.weixin.qq.com